| Mrs Carol Ann Sabatino, | |
|
91 Zane St, Wheeling, WV 26003-2292 | |
| (304) 243-0366 | |
| Not Available |
| Full Name | Mrs Carol Ann Sabatino |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 91 Zane St, Wheeling, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104007889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Carol Ann Sabatino, 91 Zane St, Wheeling, WV 26003-2292 Ph: (304) 243-0366 | Mrs Carol Ann Sabatino, 91 Zane St, Wheeling, WV 26003-2292 Ph: (304) 243-0366 |
News Archive
The inability to remember details, such as the location of objects, begins in early midlife and may be the result of a change in what information the brain focuses on during memory formation and retrieval, rather than a decline in brain function, according to a study by McGill University researchers.
Cancer cells do not grow equally well everywhere in the body. Often, they first create the conditions in which they can grow. Many years ago researchers discovered that solid tumors attract blood vessels to ensure their supply of nutrients by secreting specific factors.
A Singapore-based study has found a new health link between short sleep during pregnancy and gestational diabetes mellitus (GDM).
Researchers from the Hospital Clinic of Barcelona (Spain) have reviewed ten years' worth of scientific studies on mitochondrial toxicity in pregnant women. Exposure to toxic agents such as viruses, certain drugs, pesticides, alcohol and tobacco cause mitochondrial diseases about which very little is known, and which are transmitted from the mother to the foetus.
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company's efficacy supplement to the New Drug Application (NDA) for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 3 days ago
Molly E. Fisher, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1 Medical Park, Wheeling, WV 26003 Phone: 304-243-3000 Fax: 304-243-3060 | |
Ms. Joellen Ruckman, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 National Rd, Wheeling, WV 26003 Phone: 304-242-1390 Fax: 304-243-5880 | |
Tracy Michele Wood, M.A.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1007 Market St, Wheeling, WV 26003 Phone: 304-242-6722 | |
Martha L Hon, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 National Rd, Wheeling, WV 26003 Phone: 304-242-1390 Fax: 304-243-5880 | |
George Earl Lendon, MA-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Eoff St, Wheeling, WV 26003 Phone: 740-633-4737 | |
Jennifer L. Linzy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2203 National Rd, Wheeling, WV 26003 Phone: 304-243-0300 Fax: 304-243-0328 |